Vision in dementia: Contrast effects

Neurological Research

Volumn 18, Issue 1, 1996, Pages 9-15

  Lakshminarayanan, Vasudevan ^a   Lagrave, John ^b   Kean, Mary Louise ^b   Dick, Malcolm ^b   Shankle, Rodman ^b  

^a UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acuity; Alzheimer's disease; clinical tests; contrast sensitivity; vision

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTRAST SENSITIVITY; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MULTIINFARCT DEMENTIA; VISUAL ACUITY; VISUAL DISORDER;

EID: 0030049585     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1996.11740369     Document Type: Article

References (67)

1. Katzman R. Alzheimer's disease. N Engt J Med 1986; 314: 964-973
2. Katzman R. The prevalence and malignancy of Alzheimer's disease. A major killer. Arch Neural 1976; 33: 217-224
3. Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic nerve degeneration in Alzheimer's disease. N Engt J Med 1986; 315: 485-487
4. Blanks JC, Hinton DR, Sadun AA, Miller CA. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res 1989; 501: 364-372
5. Sadun AA, Bassi CJ. Optic nerve damage in Alzheimer's disease. Opthalmology (Rochester) 1990; 97: 9-17
6. Curcio CA, Drucker DN. Retinal ganglion cells in Alzheimer's disease and aging. Ann Neurol 1993; 33: 248-257
7. Drucker DN, Curcio CA. Retinal ganglion cells are lost with aging but not in Alzheimer's disease. Invest Ophthalmol Vis Sci (ARVO abstract) 1990; 31: 356
8. Blanks JC, Torigoe Y, Spee C, Gauderman WJ, Blanks RHI. Ganglion cell loss in macula of patients with Alzheimer's disease. Invest Ophthalmol Vis Sci (ARVO abstract) 1990; 31: 356
9. Sadun AA. The optic neuropathy of Alzheimer's disease. Metab Pediatr Syst Ophthalmol 1989; 12: 64-68
10. Hedges III TR, Barbas NR. Clinical evaluation of the retinal nerve fiber layer in Alzheimer's disease. Invest Opthalmol Vis Sci (ARVO abstract) 1990; 31: 356
11. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema and toxic neuropathy. Arch Opthalmol 1982; 100: 135-146
12. Cronin-Golomb A, Corkin S, Rizzo JF, Cohen J, Growden JH, Banks KS. Visual dysfunction in Alzheimer's disease: relation to normal aging. Ann Neurol 1991; 29: 41-52
13. Sadun AA, Borchert M, DeVita E, Hinton D, Bassi CJ. Assessment of visual impairment in patients with Alzheimer's disease. Am J Opthalmol 1987; 104: 113-120
14. Cogan DG. Visual disturbances with focal progressive dementing disease. Am J Opthalmol 1985; 100: 68-72
15. Bassi CJ, Solomon K, Young D. Vision in aging and dementia. Optom Vis Sci 1993; 70: 809-813
16. Nissen MJ, Corkin S, Buonanno FS, Growdon JH, Wray SH, Bauer J. Spatial vision in Alzheimer's disease. Ann Neurol 1985; 42: 667-671
17. Cronin-Golomb A, Corkin S. Contrast sensitivity in Alzheimer's disease. J Opt Soc Am A1987; 4: 7
18. Gilmore GC, Levy JA. Spatial contrast sensitivity in Alzheimer's disease: a comparison of two methods. Optom Vis Sci 1991; 68: 790-794.
19. Kiyosawa M, Bosley BM, Chawiuk J. Alzheimer's disease with prominent visual symptoms: clinical and metabolic evaluation. Opthalmology 1989; 96: 1077-1086
20. Trick LR, Trick GL, Morris P, Wolf M. Visual field loss in senile dementia of the Alzheimer's type (SDAT): baseline and initial prospective results. Invest Ophthalmol Vis Sci (ARVO abstract) 1994; 35: 1509
21. Pirozzolo FJ, Hansch EC. Oculomotor reaction time in dementia reflects degree of cerebral dysfunction. Science 1983; 214: 349-350
22. Jones A, Friedland RP, Koss B, Stark L. Saccadic intrusions in Alzheimer-type dementia. J Neurol 1983; 229: 189-194
23. Lakshminarayanan V, Friedland RP, Koss B, Muller EC, Stark L. The vestibular ocular reflex in Alzheimer's disease. Neuro-Ophthalmology 1986; 6: 205-208
24. Trick CL, Barris MC, Bickler-Bluth M. Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type. Ann Neurol 1989; 26: 226-231
25. Katz B, Rimmer S, Iragui V. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration? Ann Neurol 1989; 29: 221-225
26. Smith AT, Early F, Jones GH. Comparison of the effects of Alzheimer's disease, normal aging and scopolamine on human transient visual evoked potentials. Psychopharmacology 1990; 102: 535-543
27. Pollock VE, Schnider LS, Chui HC, Henderson V, Zemansky M, Sloane RB. Visual evoked potentials in dementia: a meta-analysis and empirical study of Alzheimer's disease patients. Biol Psychiatry 1989; 25: 1003-1013
28. Trick GL, Silverman SE. Visual sensitivity to motion: age-related changes and deficits in senile dementia of the Alzheimer's type. Neurology 1991; 41: 1437-1440
29. Gilmore GC, Wenk HE, Naylor LA, Koss E. Motion perception and Alzheimer's disease. J Gerontology: Psychol Sci 1994; 49: 52-57
30. Katz B, Rimmer S. Ophthalmologic manifestations of Alzheimer's disease. Survey Ophthalmol 1989; 34: 31-43
31. Pelli DG, Robson JG, Wilkens AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci 1988; 2: 187-199
32. Regan D, Neima D. Low contrast letter charts as a test of visual function. Ophthalmology 1983; 90: 1192-1200
33. Regan D. Low contrast letter charts and sine wave grating tests in opthalmological and neurological disorders. Clin Vis Sci 1988; 2: 235-250
34. Regan D. The Charles F. Prentice award Lecture 1990: Specific tests and specific blindnesses: keys, locks and parallel processing. Optom Vis Sci 1991; 68: 489-512
35. Nebes RD, Martin DC, Horn LC. Sparing of semantic memory in Alzheimer's disease. J Abnormal Psych 1984; 93: 321-330
36. Gilmore GC, Thomas CW, Klilz T, Persanyi M, Tomsak R. Contrast enhancement eliminates letter identification speed deficits in Alzheimer's disease. Invest Ophthalmol Vis Sci (ARVO abstract) 1992; 33: 1415
37. Lawton TB. Improved reading performance using individualized compensation filters for observers with losses in central vision. Ophthalmology 1989; 66: 115-126
38. Peli E, Goldstein RB, Young GM, Trempe CL, Buzney SM Image enhancement for the visually impaired. Invest Ophthalmol Vis Sci 1991; 32: 2337-2350
39. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinico-pathologic study of 57 cases. Neurology 1988; 42: 359-364
40. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992; 42: 473-480
41. Kazee AM, Eskin TA, Lapham LW, Gabriel KR, McDaniel KD, Hamill RW. Clinicopathologic correlates in Alzheimer's disease: assessment of clinical and pathologic diagnostic criteria. Alzheimer Disease and Associated Disorders 1993; 7: 152-164
42. Folstein M, Folstein S, McHugh PR. Mini-Mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12: 189-198
43. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry 1968; 114: 797-811
44. Hughes CP, Berg L, Danziger WL, Cohen LA, Martin RL. A new clinical scale for the staging of dementia. Br J Pschiatry 1982; 140: 566-572
45. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellack L, Karasu TB, eds. Geriatric Psychiatry, New York: Grune and Stratton, 1976: pp. 77-121
46. Wechsler D. WAIS-R Manual, New York: Psychological Corporation, 1981
47. Smith A. The Symbol Digit Modalities test: a neuropsychologic test for economic screening of learning and other cerebral disorders. Learning Disorders 1968; 3: 83-91
48. Morris JC, Mohns R, Rogers H, Filterbaum G, Heyman A. CERAD clinical and neuropsychological assessment of Alzheimer's disease. Psychopharm Bull 1988; 24: 641-651
49. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945; 19: 87-95
50. Boller F, Vignolo LA. Latent memory aphasia in hemispheredamaged patients: an experimental study with the Token test. Brain 1966; 89: 815-831
51. Kaplan E, Goodlgalss H, Weintraub S. The Boston Naming Test, 2nd edn, Philadelphia: Lea and Febiger, 1983
52. Benton AL, Hamsher K de S. Multilingual Aphasia Examination, Iowa City: University of Iowa Press, 1976
53. Rosen WG. Verbal fluency in aging and dementia. J Clin Neuropsych 1980; 2: 135-146
54. Reitan RM. Validity of the Trail Making Test as an indication of organic brain damage. Percept Motor Skills 1958; 8: 271-276
55. Christensen AL. Luria's Neuropsychological Investigation Text, 2nd edn, Copenhagen: Munksgaard, 1979
56. Kendrick DC, Gibson AJ, Moyes IC. The revised kendrick battery: clinical studies. Br J Soc Clin Psych 1979; 18: 329-340
57. Money JA. Standardized Road Map of Directional Sense Manual, San Rafael: Academic Therapy Publications, 1976
58. Roulearu L, Salmon DP, Burrers N, Kennedy C, McGuire K. Quantitative and qualitative analysis of clock drawing in Alzheimer's and Huntington's disease. Brain and Cognition 1992; 18: 70-87
59. Salmon DP, Thal LJ, Butters N, Heindel WC. Longitudinal evaluation of dementia of the Alzheimer's type: a comparison of 3 standardized mental status examinations. Neurology 1990; 40: 1225-1230
60. Cummings JL, Darkins A, Mendez M, Hill MA, Benson DF. Alzheimer's disease and Parkinson's disease: comparisons of speech and language alterations. Neurology 1988; 38: 680-684
61. Kirshner HS, Webb WG, Kelly MP. The naming disorder of dementia. Neuropsychologia 1984; 22: 23-30
62. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms and Commentary, New York: Oxford University Press, 1991
63. Rubin GS. Reliability and sensitivity of clinical contrast sensitivity tests. Clin Vis Sci 1988; 2: 169-177
64. Reeves BC, Wood JM, Hill AR. Vistech VCTS 6500 charts - within and between session reliability. Optom Vis Sci 1991; 68: 728-737
65. Lang A, Lakshminarayanan V, Portney V. Phenomenological model for interpreting the clinical significance of the in vitro optical transfer function. J Opt Soc Am A 1993; 10: 1600-1610
66. Steinert RF, Post CT, Brint SF, Fritch CD, Hall DL, Wilder LW, Fine IH, Lichtenstein SB, Masket S, Casebeer C, Oksman H. A prospective randomized double-masked comparison of a zonal progressive multifocal intraocular lens and a monofocal intraocular lens. Ophthalmology 1992; 99: 853-860
67. Bassi CJ, Lehmkuhle S. Clinical implications of parallel visual pathways. J Am Optom Assoc 1990; 61: 98-110